{
    "id": "correct_subsidiary_00053_0",
    "rank": 60,
    "data": {
        "url": "https://synapse.patsnap.com/organization/01c046450c311abad3e7ba36ca04de5f",
        "read_more_link": "",
        "language": "en",
        "title": "GE Healthcare AS",
        "top_image": "https://synapse-static.patsnap.com/static/synapse-logo-us.png",
        "meta_img": "https://synapse-static.patsnap.com/static/synapse-logo-us.png",
        "images": [
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/8052/6e59/ddbd/f2ee/3924/ea0c/2caf/25c5/df22e578b4db4508_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/a336/92cd/89ac/9019/f037/b4aa/ef13/44c4/b208c0334c370eb0_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/7867/fd8c/5c8f/b5b4/3b91/2d4a/03a9/b148/a017a8d7dca64a41_48w.webp",
            "https://synapse-static.patsnap.com/ssr/7d5f7b2e/_nuxt/en-corp-tree.1891d746.png",
            "https://synapse-static.patsnap.com/ssr/7d5f7b2e/_nuxt/en-drug-deal.78729d7c.png",
            "https://synapse-static.patsnap.com/ssr/7d5f7b2e/_nuxt/en-translational-medicine.b428d8c3.png",
            "https://synapse-static.patsnap.com/ssr/7d5f7b2e/_nuxt/en-profit.e8449358.png",
            "https://synapse-static.patsnap.com/ssr/7d5f7b2e/_nuxt/en-funding.a5fdebb5.png",
            "https://synapse-static.patsnap.com/ssr/7d5f7b2e/_nuxt/en-investment.6a82dd7e.png",
            "https://synapse-static.patsnap.com/ssr/7d5f7b2e/_nuxt/en-financing.27c56893.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "GE Healthcare AS",
            "Flutemetamol F-18",
            "Regadenoson",
            "Perflubutane"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Explore GE Healthcare AS with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 161 news, and 23 literature, Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, Contrast agent, Diagnostic radiopharmaceuticals, Drug:Perflutren protein-type A microspheres(GE healthcare), Regadenoson, Flutemetamol F-18, Perflubutane, Mangafodipir Trisodium.",
        "meta_lang": "en",
        "meta_favicon": "/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://synapse.patsnap.com/organization/01c046450c311abad3e7ba36ca04de5f",
        "text": ""
    }
}